These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33884171)

  • 21. Targeting Plasmodium Proteases to Block Malaria Parasite Escape and Entry.
    Paul AS; Duraisingh MT
    Trends Parasitol; 2018 Feb; 34(2):95-97. PubMed ID: 29269028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plerixafor and related macrocyclic amines are potential drug candidates in treatment of malaria by "filling the flap" region of plasmepsin enzymes.
    Abiri A
    Med Hypotheses; 2018 Sep; 118():68-73. PubMed ID: 30037618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsins.
    Jiang S; Prigge ST; Wei L; Gao Ye ; Hudson TH; Gerena L; Dame JB; Kyle DE
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2577-84. PubMed ID: 11502532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium berghei.
    Liu P; Robbins AH; Marzahn MR; McClung SH; Yowell CA; Stevens SM; Dame JB; Dunn BM
    PLoS One; 2015; 10(10):e0141758. PubMed ID: 26510189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Egress and invasion machinery of malaria: an in-depth look into the structural and functional features of the flap dynamics of plasmepsin IX and X.
    Munsamy G; Ramharack P; Soliman MES
    RSC Adv; 2018 Jun; 8(39):21829-21840. PubMed ID: 35541758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting functional residues in Plasmodium falciparum plasmepsins by combining sequence and structural analysis with molecular dynamics simulations.
    Valiente PA; Batista PR; Pupo A; Pons T; Valencia A; Pascutti PG
    Proteins; 2008 Nov; 73(2):440-57. PubMed ID: 18442137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion.
    Nasamu AS; Glushakova S; Russo I; Vaupel B; Oksman A; Kim AS; Fremont DH; Tolia N; Beck JR; Meyers MJ; Niles JC; Zimmerberg J; Goldberg DE
    Science; 2017 Oct; 358(6362):518-522. PubMed ID: 29074774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New paradigm of an old target: an update on structural biology and current progress in drug design towards plasmepsin II.
    Dan N; Bhakat S
    Eur J Med Chem; 2015 May; 95():324-48. PubMed ID: 25827401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational insights for predicting the binding and selectivity of peptidomimetic plasmepsin IV inhibitors against cathepsin D.
    Martins LS; Kruger HG; Naicker T; Alves CN; Lameira J; Araújo Silva JR
    RSC Adv; 2022 Dec; 13(1):602-614. PubMed ID: 36605626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmepsins as potential targets for new antimalarial therapy.
    Ersmark K; Samuelsson B; Hallberg A
    Med Res Rev; 2006 Sep; 26(5):626-66. PubMed ID: 16838300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The aspartic proteinase from the rodent parasite Plasmodium berghei as a potential model for plasmepsins from the human malaria parasite, Plasmodium falciparum.
    Humphreys MJ; Moon RP; Klinder A; Fowler SD; Rupp K; Bur D; Ridley RG; Berry C
    FEBS Lett; 1999 Dec; 463(1-2):43-8. PubMed ID: 10601635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant expression and enzymatic subsite characterization of plasmepsin 4 from the four Plasmodium species infecting man.
    Li T; Yowell CA; Beyer BB; Hung SH; Westling J; Lam MT; Dunn BM; Dame JB
    Mol Biochem Parasitol; 2004 May; 135(1):101-9. PubMed ID: 15287591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D.
    Zogota R; Kinena L; Withers-Martinez C; Blackman MJ; Bobrovs R; Pantelejevs T; Kanepe-Lapsa I; Ozola V; Jaudzems K; Suna E; Jirgensons A
    Eur J Med Chem; 2019 Feb; 163():344-352. PubMed ID: 30529637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
    Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic analysis of plasmepsins I and II aspartic proteases of the Plasmodium falciparum digestive vacuole.
    Luker KE; Francis SE; Gluzman IY; Goldberg DE
    Mol Biochem Parasitol; 1996 Jul; 79(1):71-8. PubMed ID: 8844673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping selectivity and specificity of active site of plasmepsins from Plasmodium falciparum using molecular interaction field approach.
    Kumar A; Ghosh I
    Protein Pept Lett; 2007; 14(6):569-74. PubMed ID: 17627598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence homology and structural analysis of plasmepsin 4 isolated from Indian Plasmodium vivax isolates.
    Rawat M; Vijay S; Gupta Y; Dixit R; Tiwari PK; Sharma A
    Infect Genet Evol; 2011 Jul; 11(5):924-33. PubMed ID: 21382523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II.
    Francis SE; Banerjee R; Goldberg DE
    J Biol Chem; 1997 Jun; 272(23):14961-8. PubMed ID: 9169469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes.
    Nöteberg D; Hamelink E; Hultén J; Wahlgren M; Vrang L; Samuelsson B; Hallberg A
    J Med Chem; 2003 Feb; 46(5):734-46. PubMed ID: 12593654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The activity and inhibition of the food vacuole plasmepsin from the rodent malaria parasite Plasmodium chabaudi.
    Martins TM; Domingos A; Berry C; Wyatt DM
    Acta Trop; 2006 Feb; 97(2):212-8. PubMed ID: 16329985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.